#Asia Pacific (APAC) Drug Delivery Devices Market - Trends and Forecast to 2024
Text
Patient Registry Software Market Size, Share, Outlook and Challenges Till 2027
Global Patient Registry Software Market: Information by Type of Registry (Disease Registries, Health Service Registries, Product Registries and others), Functionality (Population Health Management (PHM), Patient Care Management, Health Information Exchange (HIE) and others), Deployment Model (On-Premise and Cloud), End-User (Hospitals and Clinics, Government Organizations & Research Centers and Others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2027
Patient Registry Software Market Regional Insight
The primary region for patient registry software market are the Americas, Asia Pacific/APAC, MEA/Middle East & Africa and Europe.
The Americas to Most Likely Procure the Leading Position
The Americas can presumably take the lead in the global market over the next few years, considering the advances in the healthcare IT segment and the significant uptake of advanced EHRs. It is also observed that many of the renowned firms in the region are increasingly acquiring the smaller companies to solidify their market positions. Surge in government efforts to promote the use of patient registry software is also responsible for the market growth. With the aim to develop patient registry software that is more clinical research-friendly and interactive, vendors are focusing on technical innovations, which could be favorable for the regional market. A key trend among the players is the development of integrated software, which is not only cost-effective but also offers remote access to patient records.
APAC to Maintain Fastest Growth Pace in the Coming Years
APAC’s progress in the coming years is expected to be at the fastest pace, as the governments are taking up several initiatives to address the need for better patient care quality and reduced healthcare costs. The patient registry software’s strong demand in the region is also the result of the need to cut down medical errors, frequent hospital visits and diagnostics errors. This, combined with the rising cases of co-morbidity, and the substantial growth in the geriatric population segment, can foster revenue generation. Japan, South Korea, China, and India are some of the leading contenders in the APAC market; especially considering the rising adoption of cloud based patient registry solutions in these countries.
Request Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6917
Patient Registry Software Market Eminent Vendors
IFA SYSTEMS, Open Text Corporation, Dacima Software Inc, Optum, Inc., LUMEDX, ArborMetrix, phamax, IBM, IQVIA, Evado Pty. Ltd, McKesson Corporation are among some of the most eminent market vendors.
Patient Registry Software Market Synopsis
Patient registry software market 2020 is on track to obtain a CAGR of 11.08% from 2019 to 2025 (appraisal period), says Market Research Future (MRFR). MRFR adds that the global market size can touch USD 1,998.83 Million by 2025. We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.
Key Drivers and Primary Challenges
EHR’s Rising Adoption Rate to be a Major Growth Booster
Increasing deployment of electronic health records/EHR across the healthcare industry remains a prime growth booster in the patient registry software market. Regulatory authorities across developed nations promote the use of EHR solutions in healthcare practices for facilitating efficient delivery of services. Strict regulations that require implementation of electronic patient records and the escalating focus on ensuring top patient care quality would foster the demand for patient registry software in the years to come. The need to streamline and organize the voluminous patient registry databases in healthcare also works in favor of the global market.
Surge in Drug Development for Rare Diseases to Induce Growth
Patient registry software is also known for facilitating complex drug development, especially when it comes to rare disorders. Currently, in Europe, more than 700 rare disease registries are aiding the collection of historical patient records, sample size reduction and measurements, and more. The software also helps track the correct intake of certain drugs and its results, which is another feather in its cap pushing its demand. Increasing spending on clinical trials by several pharmaceutical and biotechnological firms could emerge as a significant opportunity in the future. Pharmaceutical and medical device vendors continue to benefit from the multiple patient registries pertaining to post-marketing surveillance of various devices and drugs.
Cloud-Based Solutions to Garner Significant Traction
Cloud based patient registry solutions are the fastest emerging segment in the market, since these offer innovative features like remote access and real-time tracking of data. Both private firms and government are increasingly going for cloud-based patient registry solutions instead of on-premise solutions. On the competitive front, the market is observing a number of vendors getting involved in several initiatives including mergers, new product launch, acquisitions and collaboration for higher penetration. A case in point, in November 2020, MyoKardia collaborated with PINNACLE/Veradigm and the American College of Cardiology to release its latest Patient Registry of Hypertrophic Cardiomyopathy. This patient registry software is expected to help MyoKardia in terms of post-marketing effectiveness and safety analysis of mavacamten, which is a therapeutic for treating HCM/obstructive hypertrophic cardiomyopathy.
Browse More Details at: https://www.marketresearchfuture.com/reports/patient-registry-software-market-6917
Patient Registry Software Market Segmentation
Patient registry software industry has been dissected in terms of type of registry, functionality, deployment model and end-user.
The types of registry available in the worldwide market include product registries, health service registries, disease registries, and others.
Functionality-wise, the market segments are health information exchange (HIE), patient care management, population health management (PHM), and others.
The primary deployment models are on-premise as well as cloud.
Government organizations & research centers, hospitals and clinics, and others are the top market end-users listed in the MRFR report.
Browse Related Reports at:
Clear Aligners Market Share, Size, Trends, Growth and Global Industry Analysis by 2027
Cell Therapy Market Growth, Size, Trends, Report Analysis, Forecast to 2027
Telehealth Market Trends, Size, Growth, Share, Application and Analysis by 2024 | MRFR
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
0 notes
Text
Global Type1 Diabetes Market Size, Trends, Competitive Market Size, Share, Development and Forecast Overview 2024
Summary – A Global Type1 Diabetes Market 2019 by Company, Regions, Type and Application, Forecast to 2024 -” has been featured on WiseGuyReports.
The global type1 diabetes market is expected to grow modestly during the forecast period owing to growing incidence and prevalence of diabetes and cohesive government policies. Type1 diabetes is a serious, chronic condition that is caused when insulin is not created within the body, making the glucose level too high. It is the condition when cells that.
ALSOREAD:https://www.medgadget.com/2019/05/global-type1-diabetes-market-segmentation-application-technology-market-analysis-research-report-2023.html
make insulin are attacked and destroyed by the body, it causes type1 diabetes. Out of all the diabetic patients, only 5% have type1 diabetes. The growth of the market is also dependent on technological advancement in the insulin delivery and rising demand for minimally invasive and non-invasive insulin delivery.
The other factors contributing to the growth of the market include cohesive government policies, initiatives and programs for the type1 diabetes. Apart from this, increasing chronic diseases associated with diabetes are contributing significantly to the growth of the market. However, certain factors such as high cost of the diagnosis and treatment therapies for diabetes may hamper the growth of global type1 diabetes market. Geographically, the global type1 diabetes market has been divided into North America, Europe, Asia Pacific and Rest of the World. North America dominates the global type1 diabetes market due to technological advancements and supportive government initiatives in this region. APAC is anticipated to be the most emerging market due to increasing number of diabetics due to obesity, geriatric population, and changing lifestyles of the people.
The companies contributing to the growth of global type1 market includes Abbott Laboratories, Bayer AG, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson Ltd., Merck & C0., and Pfizer Inc. Majority of the players are adopting various strategies such as mergers and acquisitions or entering into strategic alliance with other major players from the market in order to gain a competitive edge over others and enhance their presence.
Research Methodology
The market study of type1 diabetes market is incorporated by extensive primary and secondary research conducted by research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. The numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts to get first-hand information. Primary research brings authenticity to our reports.
Secondary sources include:
Financial reports of companies involved in the market
Whitepapers, research-papers and news blogs
Company websites and their product catalogue
The report is intended for hospitals, diagnostic centers, Laboratories, universities, private and government organizations for the overall market analysis and competitive analysis. The report provides in-depth analysis on pricing, market size, and intended quality of the product preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis delivering insights into the market for better business decisions.
Market Segmentation:
Global type1 diabetes market by insulin analog
Global type1 diabetes market by drug class
Global type1 diabetes market by devices
The Report covers:
Comprehensive research methodology of Global Type1 Diabetes Market.
This report also includes detailed and extensive market overview with Analyst insights & key market trends.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Type1 Diabetes Market.
Insights about market determinants which are stimulating the Global Type1 Diabetes Market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
...FOR MORE DETAILS: https://www.wiseguyreports.com/reports/3186857-global-type1-diabetes-market-research-and-forecast-2018-2023
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)
0 notes
Text
Asia Pacific (APAC) Drug Delivery Devices Market - Trends and Forecast to 2024
Asia Pacific Drug Delivery Devices Market, By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical, Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Ambulatory Surgery Centers/Clinics, Home Care Settings, Diagnostic Centers, Others), By Country (China, India, Japan, South Korea, Singapore, Australia, Rest of APAC) – Industry Trends and Forecast to 2024
APAC Drug Delivery Devices Market is expected to reach USD 235.8 billion by 2024 from USD 130.9 billion in 2016, at a CAGR of 7.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Drug delivery is a process of introducing a therapeutic effect in the human body by administering a pharmaceutical drug at a specific targeted site. Drug delivery system improves the efficacy and safety of drug by controlling the rate, time and release of drug in the body. The drug delivery market is segmented on the basis of route of administration, end users, and region.
Request-a-sample@https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-apac-drug-delivery-devices-market
· On the basis of route of administration the APAC drug delivery devices market is segmented into oral, injectable, topical, pulmonary, nasal, ocular, implantable and transmucosal. Oral drug is further segmented based on form into solid drug, semi-solid drug and liquid drug.
· The solid drugs include and are categorized as tablets, capsules, powders and pills. The semi-solid drugs are further segmented into gels, emulsions and elixirs. The liquid drugs are further classified into solutions and syrups.
· The Injectable drug delivery segment is further segmented into devices and formulations. The devices segment is categorized as conventional injections, self Injectable devices, Needle free injectors, auto injectors, pen injectors, wearable injectors, other devices. The convention injections sub-segment is further classified by material into glass and plastic injections, by usability disposable and reusable injections and, by type into fillable and pre-filled syringes.
· The Injectable drug delivery formulations are categorized as conventional drug delivery, novel drug delivery, long acting Injectable. Based on the route of administration, oral drug delivery market dominates the market in 2015 and in the near future injectable drug delivery market will dominate the APAC drug delivery devices market with the largest share in the drug delivery market. Topical drug delivery market is considered to be the fastest growing market with the CAGR of 11.5%.
Speak-to-analyst@https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-apac-drug-delivery-devices-market
The pulmonary drug delivery segment is further classified into metered dose inhalers (MDI), dry powder inhalers (DPI) and nebulizers. The nebulizers are further sub segmented into jet nebulizers, ultrasonic nebulizers and soft mist nebulizers.
Ocular drug delivery devices are segmented into liquid ocular drugs, semi solid ocular drugs and ocular devices. Liquid ocular drug delivery includes eye drops and liquid sprays. Semi solid ocular drug delivery includes gels and ointments. The ocular device includes drug coated lenses and ocular inserts.
Nasal drug delivery devices are segmented into nasal drops, powders, gels, and sprays. The topical drug delivery segment is segmented based on form into liquid, semi-solid, solid and transdermal. The transdermal topical drug delivery device includes transdermal patches and transdermal gels. The implantable drug delivery devices segment includes active and passive implantable drug delivery devices. The transmucosal drug delivery segment is sub segmented into oral transmucosal and others. The oral transmucosal segment includes products such as buccal and sunlingual drug delivery devices, while the others segment includes rectal transmucosal drug delivery and vaginal transmucosal drug delivery.
On the basis of end users the APAC drug delivery devices market is segmented into hospitals, over the counter, ambulatory surgery centers/clinics, home care settings, diagnostic centers, and others. The hospitals segment dominate the North America drug delivery devices market.
The major factors contributing to the growth of the APAC drug delivery devices market are rising prevalence of chronic diseases, growing geriatric population, increase in diagnosis, growth of biosimilars, new product launches, drug innovation, technological advancements, and decrease in the level of pain. On the other hand, factors such as side effects and injuries, infections, safety measures regarding the use of devices used for the administration of drug, patent expiry, product recall and patent cliff hampers the growth of the market.
Compotator
The major players covered in the report are Alcoa Corporation, Endurance Technologies Limited, Ryobi Limited, DyCast Specialties Corporation, Consolidated Metco, Inc., Alcast Technologies, Ningbo Beilun Create Mould Machine Co., Ltd, Leggett & Platt, Incorporated, Martinrea Honsel Germany GmbH, Gibbs, Dynacast, Reliance Foundry Co. Ltd., Toyota Industries Corporation, LA Aluminum, TPi Arcade, Drahtwerk Elisental W. Erdmann GmbH & Co., Wagstaff Inc., Ningbo Innovaw Mechanical CO.,LTD., Modern Aluminum Castings CO., INC. and Pacific Die Casting Corp.
Request for Toc@https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-apac-drug-delivery-devices-market
Global Asia Pacific (APAC) Drug Delivery Devices Market Size, Status and Forecast 2018 – 2025
1 Market Overview
2 Manufacturers Profiles
3 Global APAC Cancer Diagnostics Sales, Revenue, Market Share and Competition by Manufacturer
4 Global APAC Cancer Diagnostics Market Analysis by Regions
5 North America Global APAC Cancer Diagnostics by Countries
6 Europe Global Asia Pacific (APAC) Drug Delivery Devices by Countries
7 Asia-Pacific Asia Pacific (APAC) Drug Delivery Devices by Countries
8 South America Global Asia Pacific (APAC) Drug Delivery Devices Diagnostics by Countries
9 Middle East and Africa Global Asia Pacific (APAC) Drug Delivery Devices Diagnostics by Countries
10 APAC Cancer Diagnostics Market Segment by Type
11 Global Asia Pacific (APAC) Drug Delivery Devices Market Segment by Application
12 Global APAC Cancer Diagnostics Market Forecast
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendixes
Based on geography the market is segmented into 7 countries, China, India, Japan, South Korea, Singapore, Australia and rest of APAC. Japan is expected to dominate the market, while China and India are expected to be the growing with highest CAGR in the forecast period.
The report also includes company share analysis for the major companies operating in this market by countries. The details of mergers & acquisitions, product launches, expansions, and product life cycle matrix is also a part of this report. Some of the players in the market Bayer AG, Johnson & Johnson Services, Inc., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc. , Merck & Co., Sanofi, Antares Pharma, and 3M.
Buynow@https://www.databridgemarketresearch.com/checkout/buy/enterprise/asia-pacific-apac-drug-delivery-devices-market
Reasons to Purchase this Report
· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
· Regions/Countries that are expected to witness the fastest growth rates during the forecast period
· The latest developments, market shares, and strategies that are employed by the major market players
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
· Amyotrophic Lateral Sclerosis (ALS) Market
· Antifungal Drugs Market
· Cutaneous Lupus Erythematosus Market
0 notes
Text
Prefilled Syringes Market will Likely to Expand at a Steady CAGR of 9.3% by 2024
Prefilled Syringes Market: Snapshot
Parenteral is one of the most commonly used route of drug administration, oral administration being the most preferred one. A steady rise in the development and availability of parenteral drugs has resulted in the increasing demand for several advanced drug delivery devices that promise cost containment as well as ease of administration.
Prefilled syringes are one of the most rapidly expanding segments of the injectable drug delivery devices market. There are several benefits of prefilled syringes over traditional delivery systems: improved safety, ease of administration, accurate dosing, and reduced risk of contamination. These advantages form the basic foundation for the success of prefilled syringes and are likely to continue driving the market during the forecast period.
Obtain Report Details @
https://www.transparencymarketresearch.com/prefilled-syringes-market.html
Technical advances in the sector, rapid growth in the biologics market, and the growing preference for self-administration using autoinjectors, prefilled syringes, and pen injectors are the key factors boosting the global market for prefilled syringes.
The global sales of prefilled syringes amounted to US$3.5 bn in 2015 and is projected to reach US$7.9 bn, expanding at a CAGR of 9.3% over the period of 2016 to 2024.
Glass Prefilled Syringes to Lose Market Share Despite being Most Preferred Segment
Prefilled syringes are available in two key types – plastic (polymer) and glass – depending on the kind of material used to develop the barrel of the syringe. Despite the fact that the industry has been reporting a growing use of polymers by many manufacturers of syringes, glass is still considered to be the top-most choice and will continue to dominate the market in terms of volume as well as revenue. This is attributed to the fact that changing the perception of healthcare practitioners and manufacturers over the preference of glass over plastic is expected to be a rather gradual process. The segment of glass prefilled syringes is anticipated to lose market share toward the end of the forecast period, which will be replaced by plastic syringes. The latter is expected to grow at a CAGR of 10.8% from 2016 to 2024.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1131
By application, the market is segmented into vaccines, monoclonal antibodies, and others. On the basis of distribution channel, the prefilled syringes market is categorized into hospitals, ambulatory surgical centers, and mail order pharmacies.
Japan Most Promising Market in APAC Prefilled Syringes Market
Europe has maintained its position as the leading regional market for prefilled syringes in terms of volume (unit consumption) as well as revenue. However, the APAC market for prefilled syringes is anticipated to exhibit strong growth at a CAGR of 11.3% during the forecast period. The presence of leading drug manufacturers in the region requiring prefillable syringes and the high conversion rate from vials to prefilled syringes are the primry factors likely to support the growth of the APAC market.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1131
Asia Pacific is perceived as a follower rather than a leader when it comes to the development and adoption of new technologies. Although the prefilled syringes market is presently in its stage of infancy in APAC, factors such as improving economic conditions, the rising purchasing power of the people, the growth in awareness regarding the advantages of prefilled syringes, and the presence of a large patient suffering from various chronic diseases are expected to drive the market to register a double-digit CAGR. In Asia Pacific, Japan accounts for the major share in the market by revenue as well as volume.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: www.transparencymarketresearch.com
0 notes
Text
Decrease in Demand of Type 1 Diabetes Market to Restrict Revenue Growth During the Forecast Period 2024
Diabetes is a group of endocrine disorders, typically related to blood sugar. The three types include type 1, type 2, and gestational diabetes. Among these, type 1 diabetes is more common in children and young adults. Treated with a wide range of insulin delivery devices and drugs, type 1 diabetes (T1D) is today one of the most prevalent chronic diseases worldwide.
Research Report Insights, in its latest report titled “Type 1 Diabetes Market: Global Industry Analysis and Forecast – 2017-2024”, examines the global market for type 1 diabetes for the aforementioned six-year period.
Global Type 1 Diabetes Market: Drivers and Restraints
Primarily driven by the acceptance of latest approved therapeutics products and premium products in the pipeline, the market for type 1 diabetes treatment is currently thriving at a considerable pace. In addition to tremendously increasing T1D-inflicted population across the globe, staggeringly improved treatment options will remain the key factors fueling the growth of T1D market globally.
Request For Report Sample: https://www.researchreportinsights.com/report/upsample/120124592/Type-1-Diabetes-Market
Increasing dedicated diabetes research projects and swelling government funds for therapeutic research are also expected to elevate the market for type 1 diabetes (treatment) over the next few years. Rising preponderance of juvenile diabetes, coupled with burgeoning cases of early detection, are likely to foster the demand for T1D treatment and therapeutics on a large scale.
Development of several non-insulin therapies, such as adjuvant therapy, is currently in the pipeline. This may provide a strong impetus to the market growth in near future. Furthermore, few of the leading insulin brands, including Eli Lily, Sanofi, and Novo Nordisk, are due for patent expirations soon within a couple of years, which highlights rapid growth possibilities for the type 1 diabetes market globally.
Owing to an increasing number of chronic disease cases associated with diabetes, the recent past has seen an exploding usage of various insulin delivery devices. The advent of technology in diabetes treatment, paired up with growing patient awareness, will support the market growth during the forecast period. Diabetes control and awareness programs organized by several governments and private bodies are anticipated to further bolster the market growth.
The entry of biosimilars has been quite promising, resulting in rapid adoption in the therapeutics world. However, emergence of biosimilars can restrict the growth of type 1 diabetes treatment market. Moreover, cost-intensive diagnostics and treatment will remain longstanding challenges to market penetration in developing countries. Inadequate reimbursement policies are also estimated to restrict market growth in near future. Associated side effects can also hamper the rate of adoption.
Global Type 1 Diabetes Market: Trends and Opportunities
Research Report Insights indicated the sustenance of human insulin and insulin analogs at the forefront among all the therapies, owing to the fact that no other therapeutic alternatives assure complete regeneration of the pancreatic beta cells. Moreover, various new T1D therapies are queued for approval post-2016. These trends will drive market in near future. A host of opportunities lies in the juvenile diabetes sector.
Some of the strongest trends in the T1D market, include development of a new class of diabetes drugs, emergence of a range of non-invasive diabetes diagnostics and drug delivery devices. These trends are likely to create multiple growth opportunities in the type 1 diabetes market. Another popular trends is the growing demand for home infusion therapy and artificial pancreas for addressing diabetes.
Request Report For Toc: https://www.researchreportinsights.com/report/TOC/120124592/Type-1-Diabetes-Market
Global Type 1 Diabetes Market: Regional Analysis
Research Report Insights’s report evaluates the following key geographies:
North America (the U.S, Canada)
Europe (France, Germany, Italy, Spain, and the U.K.)
Eastern Europe
CIS
Asia Pacific (China, India, Japan, Australia, others)
Latin America (Argentina, Brazil, others)
North America is currently dominating the global type 1 diabetes market, and will possibly continue its dominance throughout the forecast period. Massive rise in type 1 diabetes cases across North America and highly advanced healthcare infrastructure to address the prevalence of diabetes, will play the key role in boosting the market for type 1 diabetes treatment in this region. Despite sustainably higher costs for diabetes treatment and therapeutics compared to other developed regions, the U.S. is likely to remain the key market for type 1 diabetes over the next few years.
APAC is expected to witness substantial growth during the next few years, by 2021 end. Growing diabetes incidences, increasing geriatric population, and rising life expectancy will collectively fuel the market in this region, especially in Japan, China, and India. Besides the U.S. and Japan, the U.K., Canada, France, Germany, Spain, and Italy will also continue to represent major markets for type 1 diabetes.
Global Type 1 Diabetes Market: Key Players
Some of the key players in the global type 1 diabetes market are Sanofi-Aventis US, LLC, Novo Nordisk A/S, Eli Lilly and Company, B. Braun Melsungen AG, Biodel, Inc., DiaVacs, Inc., Macrogenics, Inc., XOMA Corp., and Astrazeneca Plc.
Report Analysis: https://www.researchreportinsights.com/report/upcomming/120124592/Type-1-Diabetes-Market
0 notes
Text
Microfluidic Devices Market Top Trends, Growth Factors, Top Companies Analysis and Outlook till 2023
Market Research Future (MRFR) has published a detailed report stating the Global Microfluidic Devices Market. The report offers insights into the leading market players and presents an assessment of their current market position.
Global Microfluidic Devices Market - Overview
A microfluidic device is a well-accepted technology and has several applications. The technology allows integration of many medical tests on a single chip. It has become an essential technology for integration, industrialization, miniaturization and parallelization of various tests in the fields of diagnostics, drug development and biological research. The technology also helps in reducing the side effects and improving the efficacy of treatment. New microfluidic methods are used for evaluating drugs and manipulating cells for the treatment of diseases related to heart and cancer
Request Sample Copy at https://www.marketresearchfuture.com/sample_request/684
Globally, the market for microfluidic devices is gaining significant importance due to growing R&D investment in life sciences, pharmaceuticals, increasing point of care testing demand and An increase in point of care testing, as an effective method for delivery of treatment, has also led to increase in the demand for microfluidic devices in the global market
Some other factors driving the microfluidic devices market are rise in the commercial and analytical application of these devices and use of microfluidic products for miniaturization of chip.
Moreover some of the challenges faced by the market are adherence to stringent regulatory requirements to decelerate growth and geometrical and surface chemistry issues.
The use of microfluidic devices has been gaining importance into recent classification of research areas that target integration of laboratory protocols into miniaturized devices known as lab on chip.
This process includes many steps such as mixing, pre-treatment, reaction, separation, and pre-concentration. These processes help to reduce the cost and consume less reagent/sample, which is further helpful in various medical diagnosis with the help of blood drop. The miniaturization technique is expected to drive the microfluidic devices market, as this technique helps to reduce the overall cost of screening the compounds for cell biology problems by the pharmaceutical companies. Also the miniaturization technique helps in the reduction of analysis time and carry parallel assay in microfluidic devices, which is further expected to support the growth of this market.
Competitive Analysis:
Hoffmann-la Roche AG, Abbott laboratories, Siemens healthcare GMBH, Agilent technologies, Inc., Fluidigm corporation, bio-rad laboratories, ink, Cepheid, Raindance technologies, Inc., Dolomite centre, Micronit microfluidics, Johnson & Johnson, Becton, Dickinson and Company, These are some of the prominent players at the forefront of competition in the Global Microfluidic Devices Market..
Global Microfluidics Device Market – Segments
The MRFR analysis is segmented into four key dynamics for the convenience of understanding;
By Application: Drug Delivery, Pharmaceutical, Analytical Device, Environmental & Industrial, and Life Science Research.
By Industry: Microfluidics and Microfluidic Devices and others.
By Material: Glass, Polymer, and Silicon.
By Regions: North America, Europe, APAC, and the Rest-of-the-World
Browse Complete 30 Pages Premium Research Report Enabled with Respective Tables and Figures at https://www.marketresearchfuture.com/reports/microfluidics-device-arket-684
Regional Analysis:
North America is the largest market for microfluidic devices in 2015 with the U.S. clearly in the lead position. The faster uptake of technology, large biotech industry of the U.S., presence of large global players, growing prevalence of infectious diseases which is propelling the molecular diagnostics industry and other factors are driving the U.S. market.
Europe is the second-largest market as well as the second fastest growing region during the forecasted period led by Germany, U.K. and France. Asia is expected to be the fastest growing region with a CAGR of 22.8% during the forecast period of 2016 to 2024. Asia Pacific region is expected to be led by Japan followed by China, South Korea and India.
The Middle East and Africa market is expected generate slower growth on account of poor biotech and pharmaceutical industry and low demand due to poor socio-economic conditions.
Major TOC of Global Microfluidics Device Market Research Report -Forecast to 2024:
1 Report Excerpts
2 Market Definition
3 Research Methodology
4 Forecast Indicators
5 Market Analysis
6 Microfluidic device, Market Value & Volume Forecast (2011-2024)
7 Microfluidic device, by Industry Market Value & Volume Forecast (2011-2024)
8 Microfluidic device, by Application Market Value & Volume Forecast (2011-2024)
TOC CONTINUED…!
View more Information about This Report at https://www.medgadget.com/2018/11/microfluidic-devices-market-racing-to-a-heightened-growth-with-cagr-of-19-7-till-2023-reveals-mrfr.html
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: [email protected]
0 notes
Text
Europe Injectable Drug Delivery Market to Reach Valuation of US$ 265.0 Billion by 2024, Says –Baxter International Inc., Becton,Dickinson and Company, Gerresheimer AG
Europe Injectable Drug Delivery Market is estimated at USD 107.4 billion in 2016 and is projected to reach USD 265.0 billion by 2024, at a CAGR of 11.9% during the forecast period from 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Free Download Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=europe-injectable-drug-delivery-market
According to Data Bridge Market Research new market report “Europe Injectable Drug Delivery Market”
Competitive Landscape:
The market report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their position in the market.
Major Players:
Some of the major players operating in this market are:
Baxter International, Inc.
Becton
Dickinson and Company
Gerresheimer AG
Pfizer, Inc.
Schott AG
Alkermes Plc.
Eli Lilly and Company
Sandoz
Terumo Corporation
Teva Pharmaceuticals Industries Ltd
Among others.
Market Segmentation:
By Type
Devices (Conventional, Self),
Formulations (Conventional, Noble, Long Acting)
By Applications
Autoimmune Diseases,
Hormonal Disorders,
Orphan Diseases,
Oncology
By Usage Pattern
Curative Care,
Immunizations,
Other Usage Patterns,
Mode of Administration
Skin,
Circulatory,
Organs,
Central Nervous System
End User
Hospitals,
Clinics,
Home Care Settings,
Research Laboratories
Geographical Segmentation:
Based on geography, the Europe injectable drug delivery market is segmented into 11 major countries such as
Germany,
France,
U.K.,
Belgium,
Switzerland,
Italy,
Spain,
Russia,
Turkey,
Netherlands, and
Rest of Europe.
Exclusive Market Research Report News @ https://databridgemarketresearch.com/news/product-launch/europe-injectable-drug-delivery-market/
Browse Related Reports:
APAC Injectable Drug Delivery Market By Type {Devices (Conventional, Self), Formulations (Conventional, Noble, Long Acting)} Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology) Usage Pattern (Curative Care, Immunizations,) Mode of Administration (Skin, Circulatory, Organs, Central Nervous System) End User (Hospitals, Clinics, Home Care Settings, Research Laboratories) Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of APAC) – Industry Trends and Forecast to 2024
http://databridgemarketresearch.com/reports/asia-pacific-injectable-drug-delivery-market/
About Us:
Data Bridge Market Research adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us-
Data Bridge Market Research
US: +1-888-387-2818
Email: [email protected]
Website: https://databridgemarketresearch.com
#Europe Injectable Drug Delivery Analysis#Europe Injectable Drug Delivery Industry Analysis#Europe Injectable Drug Delivery Market#Europe Injectable Drug Delivery Market Forecast#Europe Injectable Drug Delivery Research Reports
0 notes
Text
Patient Registry Software Market Future Outlook, Growth and Emerging Trends Till 2027
Global Patient Registry Software Market: Information by Type of Registry (Disease Registries, Health Service Registries, Product Registries and others), Functionality (Population Health Management (PHM), Patient Care Management, Health Information Exchange (HIE) and others), Deployment Model (On-Premise and Cloud), End-User (Hospitals and Clinics, Government Organizations & Research Centers and Others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2027
Patient Registry Software Market Regional Insight
The primary region for patient registry software market are the Americas, Asia Pacific/APAC, MEA/Middle East & Africa and Europe.
The Americas to Most Likely Procure the Leading Position
The Americas can presumably take the lead in the global market over the next few years, considering the advances in the healthcare IT segment and the significant uptake of advanced EHRs. It is also observed that many of the renowned firms in the region are increasingly acquiring the smaller companies to solidify their market positions. Surge in government efforts to promote the use of patient registry software is also responsible for the market growth. With the aim to develop patient registry software that is more clinical research-friendly and interactive, vendors are focusing on technical innovations, which could be favorable for the regional market. A key trend among the players is the development of integrated software, which is not only cost-effective but also offers remote access to patient records.
APAC to Maintain Fastest Growth Pace in the Coming Years
APAC’s progress in the coming years is expected to be at the fastest pace, as the governments are taking up several initiatives to address the need for better patient care quality and reduced healthcare costs. The patient registry software’s strong demand in the region is also the result of the need to cut down medical errors, frequent hospital visits and diagnostics errors. This, combined with the rising cases of co-morbidity, and the substantial growth in the geriatric population segment, can foster revenue generation. Japan, South Korea, China, and India are some of the leading contenders in the APAC market; especially considering the rising adoption of cloud based patient registry solutions in these countries.
Request Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6917
Patient Registry Software Market Eminent Vendors
IFA SYSTEMS, Open Text Corporation, Dacima Software Inc, Optum, Inc., LUMEDX, ArborMetrix, phamax, IBM, IQVIA, Evado Pty. Ltd, McKesson Corporation are among some of the most eminent market vendors.
Patient Registry Software Market Synopsis
Patient registry software market 2020 is on track to obtain a CAGR of 11.08% from 2019 to 2025 (appraisal period), says Market Research Future (MRFR). MRFR adds that the global market size can touch USD 1,998.83 Million by 2025. We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.
Key Drivers and Primary Challenges
EHR’s Rising Adoption Rate to be a Major Growth Booster
Increasing deployment of electronic health records/EHR across the healthcare industry remains a prime growth booster in the patient registry software market. Regulatory authorities across developed nations promote the use of EHR solutions in healthcare practices for facilitating efficient delivery of services. Strict regulations that require implementation of electronic patient records and the escalating focus on ensuring top patient care quality would foster the demand for patient registry software in the years to come. The need to streamline and organize the voluminous patient registry databases in healthcare also works in favor of the global market.
Surge in Drug Development for Rare Diseases to Induce Growth
Patient registry software is also known for facilitating complex drug development, especially when it comes to rare disorders. Currently, in Europe, more than 700 rare disease registries are aiding the collection of historical patient records, sample size reduction and measurements, and more. The software also helps track the correct intake of certain drugs and its results, which is another feather in its cap pushing its demand. Increasing spending on clinical trials by several pharmaceutical and biotechnological firms could emerge as a significant opportunity in the future. Pharmaceutical and medical device vendors continue to benefit from the multiple patient registries pertaining to post-marketing surveillance of various devices and drugs.
Cloud-Based Solutions to Garner Significant Traction
Cloud based patient registry solutions are the fastest emerging segment in the market, since these offer innovative features like remote access and real-time tracking of data. Both private firms and government are increasingly going for cloud-based patient registry solutions instead of on-premise solutions. On the competitive front, the market is observing a number of vendors getting involved in several initiatives including mergers, new product launch, acquisitions and collaboration for higher penetration. A case in point, in November 2020, MyoKardia collaborated with PINNACLE/Veradigm and the American College of Cardiology to release its latest Patient Registry of Hypertrophic Cardiomyopathy. This patient registry software is expected to help MyoKardia in terms of post-marketing effectiveness and safety analysis of mavacamten, which is a therapeutic for treating HCM/obstructive hypertrophic cardiomyopathy.
Browse More Details at: https://www.marketresearchfuture.com/reports/patient-registry-software-market-6917
Patient Registry Software Market Segmentation
Patient registry software industry has been dissected in terms of type of registry, functionality, deployment model and end-user.
The types of registry available in the worldwide market include product registries, health service registries, disease registries, and others.
Functionality-wise, the market segments are health information exchange (HIE), patient care management, population health management (PHM), and others.
The primary deployment models are on-premise as well as cloud.
Government organizations & research centers, hospitals and clinics, and others are the top market end-users listed in the MRFR report.
Browse Related Reports at:
Durable Medical Equipment Market Size, Share, Trends and Industry Analysis to 2027
Scoliosis Treatment Market Overview, Share Analysis and Global Forecast to 2027
Telehealth Market Trends, Size, Growth, Share, Application and Analysis by 2024 | MRFR
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
0 notes
Text
Global Infusion Pump Systems, Accessories and Software Market Trends, Outlook 2017-2024
Data Bridge Market Research new Insight’s on “Global Infusion Pump Systems, Accessories and Software Market is projected to reach 13.3 billion by 2024, from USD 8.4 billion in 2016 growing at a CAGR of 5.9% during the forecast period of 2017 to 2024”.
Request for free sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=infusion-pump-market-accessories-software-market
The market is segmented by Type {Systems (Volumetric, Syringe, Anesthesia), Accessories (Valve Catheters, IV Sets), Management Software (EMR, Respiratory) Application (General, Pain and Anesthesia, Insulin, Enteral) End-User (Hospitals, Ambulatory, Clinics) Geography (North America, Europe, APAC, South America, MEA) – Trends and Forecast to 2024
The actual calculation year for the report is 2016, while the historic data is for 2015 and the forecast period is still 2024.
Segmentation: Global Infusion Pump Systems, Accessories and Software Market Categories
· The global infusion pump system, accessories and software market is segmented on the basis of type, application, end-user, distribution channel, and geography.
· On the basis of type, the infusiom pump systems, accessories and software market is segmented into infusion pump systems, infusion pump accessories and infusion pump management software. The infusion pump systems market segment is further categorized on the basis of product type into volumetric infusion pump, syringe infusion pump, ambulatory infusion pump, enteral infusion pump, insulin infusion pump, implantable infusion pump, anesthesia infusion pump, and chemotherapy infusion pump. The infusion pump accessories market segment is categorized into infusion administration sets, valve catheters, IV sets, needleless connectors and others. The infusion pump management software market segment in segmented on the basis of module type, into asset management modules, EMR modules, respiratory monitoring modules and others.
Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=infusion-pump-market-accessories-software-market
· The infusion pump systems, accessories and software market is also segmented on the basis of end users, into hospitals, ambulatory, home healthcare, clinics and others. The hospitals segment is expected to dominate the market in 2017, however the ambulatory and home healthcare segment is expected to grow at the highest CAGR and be the major driving factors for this market.
· On the basis of application, the infusion pump systems, accessories and software market is segmented into general infusion, pain and anesthesia management, insulin infusion, enteral infusion, chemotherapy and others. The general infusion market segment is expected to dominate the market in 2017, and the insulin infusion segment is expected to grow at the highest CAGR in the forecast period 2017 to 2024.
· The infusion pump system, accessories and software market is highly fragmented with various companies operating in local regions. The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. For instance: in October 2016, ICU Medical Inc., acquired the Hospira Infusion Systems business from Pfizer Inc.; in November 2016, Becton, Dickinson and Company entered into a development agreement with JDRF, to focus on creating technological development on extended wear insulin infusion sets. The report includes company share data for different geographies including global, North America, Europe, APAC, South America, and MEA.
· Based on geography, the market is segmented into five geographical regions, North America, Europe, Asia-Pacific, South America, and Middle East and Africa. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others. In 2017, North America is expected to dominate the infusion pump systems, accessories and software market with 51.9 percent market share followed by Europe and APAC.
Recent Developments: Global Infusion Pump Systems, Accessories and Software Market
The major driving factor for this market is increasing incidence of diabetes and other chronic diseases along with increased acceptance of ambulatory and disposable infusion pumps in home healthcare, is expected to fuel the growth of this market in the forecast period 2017 to 2024. The market is also expected to grow owing to the significant development in drug delivery infusion pumps and patient monitored anesthetic infusion pumps.
Company Share Analysis: Global Infusion Pump Systems, Accessories and Software Market
Some of the major players operating in the infusiom pump systems, accessories and software market are
· Becton,
· Dickinson and Company (BD),
· Smiths Group plc,
· F. Hoffmann-La Roche Ltd.,
· Terumo Europe NV,
· Cane S.p.A.,
· Caesarea Medical Electronics,
· HYH,
· B. Braun Melsungen AG,
· Baxter,
· Fresenius SE & Co. KGaA,
· Hospira, Inc. (A Pfizer Company),
· Animas Corporation,
· Medtronic,
· Moog Inc.,
· Micrel Medical Devices SA,
· Shenzhen Mindray Bio-Medical Electronics Co., Ltd.,
· ZynoMed.com,
· Zoll Medical,
· tricumed Medizintechnik GmbH,
· Teleflex Incorporated,
· ICU Medical, Inc.,
· Novo Nordisk A/S,
· AngioDynamics among others.
Access Full Report: https://databridgemarketresearch.com/reports/infusion-pump-market-accessories-software-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
#Global Infusion Pump Systems Accessories and Software Market report#Global Infusion Pump Systems Accessories and Software Market trend#Global Infusion Pump Systems Accessories and Software Market Segments#Global Infusion Pump Systems Accessories and Software Market size
0 notes
Text
Type 1 Diabetes Market healthy pace throughout 2024
Diabetes is a group of endocrine disorders, typically related to blood sugar. The three types include type 1, type 2, and gestational diabetes. Among these, type 1 diabetes is more common in children and young adults. Treated with a wide range of insulin delivery devices and drugs, type 1 diabetes (T1D) is today one of the most prevalent chronic diseases worldwide.
Research Report Insights, in its latest report titled “Type 1 Diabetes Market: Global Industry Analysis and Forecast – 2017-2024”, examines the global market for type 1 diabetes for the aforementioned six-year period.
Global Type 1 Diabetes Market: Drivers and Restraints
Primarily driven by the acceptance of latest approved therapeutics products and premium products in the pipeline, the market for type 1 diabetes treatment is currently thriving at a considerable pace. In addition to tremendously increasing T1D-inflicted population across the globe, staggeringly improved treatment options will remain the key factors fueling the growth of T1D market globally.
Increasing dedicated diabetes research projects and swelling government funds for therapeutic research are also expected to elevate the market for type 1 diabetes (treatment) over the next few years. Rising preponderance of juvenile diabetes, coupled with burgeoning cases of early detection, are likely to foster the demand for T1D treatment and therapeutics on a large scale.
Report For Report Sample with Table of Contents@ https://www.researchreportinsights.com/report/upsample/120124592/Type-1-Diabetes-Market
Development of several non-insulin therapies, such as adjuvant therapy, is currently in the pipeline. This may provide a strong impetus to the market growth in near future. Furthermore, few of the leading insulin brands, including Eli Lily, Sanofi, and Novo Nordisk, are due for patent expirations soon within a couple of years, which highlights rapid growth possibilities for the type 1 diabetes market globally.
Owing to an increasing number of chronic disease cases associated with diabetes, the recent past has seen an exploding usage of various insulin delivery devices. The advent of technology in diabetes treatment, paired up with growing patient awareness, will support the market growth during the forecast period. Diabetes control and awareness programs organized by several governments and private bodies are anticipated to further bolster the market growth.
The entry of biosimilars has been quite promising, resulting in rapid adoption in the therapeutics world. However, emergence of biosimilars can restrict the growth of type 1 diabetes treatment market. Moreover, cost-intensive diagnostics and treatment will remain longstanding challenges to market penetration in developing countries. Inadequate reimbursement policies are also estimated to restrict market growth in near future. Associated side effects can also hamper the rate of adoption.
Request For Report Discount@ https://www.researchreportinsights.com/report/updiscount/120124592/Type-1-Diabetes-Market
Global Type 1 Diabetes Market: Trends and Opportunities
Research Report Insights indicated the sustenance of human insulin and insulin analogs at the forefront among all the therapies, owing to the fact that no other therapeutic alternatives assure complete regeneration of the pancreatic beta cells. Moreover, various new T1D therapies are queued for approval post-2016. These trends will drive market in near future. A host of opportunities lies in the juvenile diabetes sector.
Some of the strongest trends in the T1D market, include development of a new class of diabetes drugs, emergence of a range of non-invasive diabetes diagnostics and drug delivery devices. These trends are likely to create multiple growth opportunities in the type 1 diabetes market. Another popular trends is the growing demand for home infusion therapy and artificial pancreas for addressing diabetes.
Global Type 1 Diabetes Market: Regional Analysis
Research Report Insights’s report evaluates the following key geographies:
North America (the U.S, Canada)
Europe (France, Germany, Italy, Spain, and the U.K.)
Eastern Europe
CIS
Asia Pacific (China, India, Japan, Australia, others)
Latin America (Argentina, Brazil, others)
North America is currently dominating the global type 1 diabetes market, and will possibly continue its dominance throughout the forecast period. Massive rise in type 1 diabetes cases across North America and highly advanced healthcare infrastructure to address the prevalence of diabetes, will play the key role in boosting the market for type 1 diabetes treatment in this region. Despite sustainably higher costs for diabetes treatment and therapeutics compared to other developed regions, the U.S. is likely to remain the key market for type 1 diabetes over the next few years.
APAC is expected to witness substantial growth during the next few years, by 2021 end. Growing diabetes incidences, increasing geriatric population, and rising life expectancy will collectively fuel the market in this region, especially in Japan, China, and India. Besides the U.S. and Japan, the U.K., Canada, France, Germany, Spain, and Italy will also continue to represent major markets for type 1 diabetes.
Report Analysis@ https://www.researchreportinsights.com/report/upcomming/120124592/Type-1-Diabetes-Market
Global Type 1 Diabetes Market: Key Players
Some of the key players in the global type 1 diabetes market are Sanofi-Aventis US, LLC, Novo Nordisk A/S, Eli Lilly and Company, B. Braun Melsungen AG, Biodel, Inc., DiaVacs, Inc., Macrogenics, Inc., XOMA Corp., and Astrazeneca Plc.
0 notes
Text
Pre Filled Syringes Market | Forecast 2018 to 2024
Pre Filled Syringes Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024
Prefilled syringes market report gives a comprehensive outlook on prefilled syringes across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on prefilled syringes market gives historical, current, and future market sizes (US$ Mn) on the basis of material type, prefilled syringes type, design, end user, and geographic regions. This report studies prefilled syringes market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, prefilled syringes market report includes new product introduction, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed prefilled syringes market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the prefilled syringes market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of prefilled syringes.
A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-pre-filled-syringes-market/#ulp-4H8Z4LpNMLEuOnnx
The global prefilled syringes market has been segmented based on material, design, drug class, application, and geography
Based on material, the global prefilled syringes market is segmented as:
· Glass
· Plastic
Based on design, the global prefilled syringes market is segmented as:
· Single Chamber
· Dual Chamber
· Customized
Based on drug class, the global prefilled syringes market is segmented as:
· Biologics
· Biosimilars
· Vaccines
· Others ( Anticoagulants, Antirheumatics)
Based on the application, the global prefilled syringes market is segmented as:
· Rheumatoid Arthritis
· Anaphylaxis
· Diabetes
· Others ( Cancer, Multiple Sclerosis)
To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-pre-filled-syringes-market/#ulp-c654SbFYO64MsOhu
Prefilled syringes are procuring the acceptance in market as a drug delivery systems which is designed for the injectable drugs. Prefilled syringes are generally preferred to the parenteral administration of the drugs and can be used mainly in treating chronic diseases where patients have to self-administer their medication, many times a week. Self-injecting devices consist of precise volumes of dose and already reconstituted drugs, which are helping in the elimination of the errors concerning dosage volumes and wastage of the drugs. Coping with the trend, most of the pharma companies are focusing to bring advancements in the therapies of self-administration. For example, EpiPen auto-injector and in the same way in July 2016, Bristol-Myers Squibb launched ORENCIA Clickject auto-injector commercially.
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-pre-filled-syringes-market/#ulp-14mlyhjMGhVjZqa3
Based on the geographical regions, the global Prefilled syringes market is segmented into five key regions, Asia-Pacific, Europe, North America, Latin America and Middle East & Africa Europe is the leading market for the prefilled syringes in terms of both volume and revenue. Asia pacific region is expected to show significant growth. Though the prefilled syringes market is in infant stage in APAC, factors like rising economic conditions, increase in purchasing power of people, rise in growth of awareness about the advantages of prefilled syringes, and the presence of large patients suffering with various chronic diseases are anticipated to drive the market. Japan accounts the major share of market in the Asia-Pacific market can be attributed to the increase in demand for self-administered treatments and high penetration of self-injection devices, rise in aging population, and increase in the prevalence of diabetes.
Some of the players in the global prefilled syringes market include SCHOTT AG (Germany), Gerresheimer (Germany), Medtronic (U.S.), Unilife Corporation (U.S.), Baxter International, Becton Dickinson & Co. (U.S.), Terumo Corporation (Japan), Stevanato Group (Italy), Vetter International (Ireland), and West Pharmaceuticals(U.S.)
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-pre-filled-syringes-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: [email protected]
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
0 notes
Text
Asia Pacific Medical Device Packaging Market – Trends and Forecast to 2024
Asia Pacific Medical Device Packaging Market, By Drug Delivery Device Packaging (Injectable, Topical, Nasal, Pulmonary, Transdermal, Ocular), Container Type (Pouches, Bags, Blister Packaging, Clamshells, Boxes), Raw Material (Plastics Paper and Paper board, Glass), End User (Medical Manufacturing, Contract Packaging, Retail Packaging), Distribution Channel, Geography – Industry Trends and Forecast to 2024
Asia Pacific Medical Device Packaging Market is expected to reach USD 8,892.6 million by 2024, from USD 5,054.4 million in 2016 growing at a CAGR of 7.4% in the forecast period 2017 to 2024.The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Request-a-sample@https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-medical-device-packaging-market
Asia Pacific Medical Device Packaging Market Size, Status and Forecast 2018 – 2025
· Asia Pacific Medical Device Packaging Market Overview
· Asia Pacific Medical Device Packaging Market Manufacturers Profiles
· Asia Pacific Medical Device Packaging Market Sales, Revenue, Market Share and Competition by Manufacturer
· Asia Pacific Medical Device Packaging Market Analysis by Regions
· Asia Pacific Medical Device Packaging Market by Countries
· Asia Pacific Medical Device Packaging Market Segment by Type
· Asia Pacific Medical Device Packaging Market Segment by Application
· Asia Pacific Medical Device Packaging MarketForecast
· Sales Channel, Distributors, Traders and Dealers
· Research Findings and Conclusion
· Appendixes
Get Detailed Toc @https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-medical-device-packaging-market
Market Segmentation: Asia Pacific Medical Device Packaging Market
The Asia Pacific medical device packaging market is segmented on the basis of drug delivery device packaging, container type, raw material, end user, distribution channel, and geography. In 2017, the injectable packaging segment is expected to dominate the market with a share of ~30.5% and is expected to continue this trend till 2024.
On the basis of container type, the Asia Pacific medical device packaging market is segmented into Pouches, bags, blister packaging, clamshells, boxes and others.
By raw material, the market is segmented into plastics, paper & paper board, glass and others. Plastic is further sub-segmented into polyethylene, polypropylene and others. Polyethylene is sub-segmented into high-density polyethylene and low-density polyethylene.
On the basis of end users, the market is classified into medical manufacturing, contract packaging, retail packaging and others. In 2017, the medical manufacturing segment is expected to dominate the market and contract packaging is expected to grow with the highest CAGR in the forecast period.
On the basis of distribution channel, the market is classified into direct tenders and retail. In 2017, the direct tenders segment is expected to dominate the market and is expected to continue this trend till 2024.
On the basis of geography APAC medical device packaging market is segmented into Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of APAC.
Speak-to-analyst@https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-medical-device-packaging-market
Key Drivers: Asia Pacific Medical Device Packaging Market
Some of the major factors driving the market for medical device packaging market are growing medical device market, government initiatives and low labor cost.
Key Points: Asia Pacific Medical Device Packaging Market
APAC medical device packaging market is dominated by Amcor Limited followed by Bemis Company Inc. and Berry Global Inc. along with others such as DuPont, CONSTANTIA, Texchem Polymer Engineering Division, Klöckner Pentaplast, Technipaq Inc., Plastic Ingenuity, and Beacon Converters, Inc., among others.
· Injectable drug delivery device packaging market is growing with the highest CAGR.
· Plastic is holding the major share in Asia Pacific medical device packaging market and is growing with highest CAGR.
· Medical manufacturing is dominating the medical device packaging market whereas contract packaging is expected to grow with the highest CAGR in the forecast period.
· In 2017, China is expected to dominate the Asia Pacific medical device packaging market.
Buy Now @https://www.databridgemarketresearch.com/checkout/buy/enterprise/asia-pacific-medical-device-packaging-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
RELATED REPORTS
· Global Medical Device Packaging Market
· Europe Medical Device Packaging Market
· North America Medical Device Packaging Market
#Asia Pacific Medical Device Packaging Market#Asia Pacific Medical Device Packaging Marketforcast#Asia Pacific Medical Device Packaging Markettrands#Asia Pacific Medical Device Packaging Marketshare
0 notes
Text
Prefilled Syringes Market is Projected to Surpass US$7.9 bn by 2024
Prefilled Syringes Market: Snapshot
Parenteral is one of the most commonly used route of drug administration, oral administration being the most preferred one. A steady rise in the development and availability of parenteral drugs has resulted in the increasing demand for several advanced drug delivery devices that promise cost containment as well as ease of administration.
Prefilled syringes are one of the most rapidly expanding segments of the injectable drug delivery devices market. There are several benefits of prefilled syringes over traditional delivery systems: improved safety, ease of administration, accurate dosing, and reduced risk of contamination. These advantages form the basic foundation for the success of prefilled syringes and are likely to continue driving the market during the forecast period.
Obtain Report Details @
https://www.transparencymarketresearch.com/prefilled-syringes-market.html
Technical advances in the sector, rapid growth in the biologics market, and the growing preference for self-administration using autoinjectors, prefilled syringes, and pen injectors are the key factors boosting the global market for prefilled syringes.
The global sales of prefilled syringes amounted to US$3.5 bn in 2015 and is projected to reach US$7.9 bn, expanding at a CAGR of 9.3% over the period of 2016 to 2024.
Glass Prefilled Syringes to Lose Market Share Despite being Most Preferred Segment
Prefilled syringes are available in two key types – plastic (polymer) and glass – depending on the kind of material used to develop the barrel of the syringe. Despite the fact that the industry has been reporting a growing use of polymers by many manufacturers of syringes, glass is still considered to be the top-most choice and will continue to dominate the market in terms of volume as well as revenue. This is attributed to the fact that changing the perception of healthcare practitioners and manufacturers over the preference of glass over plastic is expected to be a rather gradual process. The segment of glass prefilled syringes is anticipated to lose market share toward the end of the forecast period, which will be replaced by plastic syringes. The latter is expected to grow at a CAGR of 10.8% from 2016 to 2024.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1131
By application, the market is segmented into vaccines, monoclonal antibodies, and others. On the basis of distribution channel, the prefilled syringes market is categorized into hospitals, ambulatory surgical centers, and mail order pharmacies.
Japan Most Promising Market in APAC Prefilled Syringes Market
Europe has maintained its position as the leading regional market for prefilled syringes in terms of volume (unit consumption) as well as revenue. However, the APAC market for prefilled syringes is anticipated to exhibit strong growth at a CAGR of 11.3% during the forecast period. The presence of leading drug manufacturers in the region requiring prefillable syringes and the high conversion rate from vials to prefilled syringes are the primry factors likely to support the growth of the APAC market.
Request Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1131
Asia Pacific is perceived as a follower rather than a leader when it comes to the development and adoption of new technologies. Although the prefilled syringes market is presently in its stage of infancy in APAC, factors such as improving economic conditions, the rising purchasing power of the people, the growth in awareness regarding the advantages of prefilled syringes, and the presence of a large patient suffering from various chronic diseases are expected to drive the market to register a double-digit CAGR. In Asia Pacific, Japan accounts for the major share in the market by revenue as well as volume.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: www.transparencymarketresearch.com
0 notes
Text
Type 1 Diabetes Market to Flourish with an Impressive During by 2024
Diabetes is a group of endocrine disorders, typically related to blood sugar. The three types include type 1, type 2, and gestational diabetes. Among these, type 1 diabetes is more common in children and young adults. Treated with a wide range of insulin delivery devices and drugs, type 1 diabetes (T1D) is today one of the most prevalent chronic diseases worldwide.
Research Report Insights, in its latest report titled “Type 1 Diabetes Market: Global Industry Analysis and Forecast – 2017-2024”, examines the global market for type 1 diabetes for the aforementioned six-year period.
Global Type 1 Diabetes Market: Drivers and Restraints
Primarily driven by the acceptance of latest approved therapeutics products and premium products in the pipeline, the market for type 1 diabetes treatment is currently thriving at a considerable pace. In addition to tremendously increasing T1D-inflicted population across the globe, staggeringly improved treatment options will remain the key factors fueling the growth of T1D market globally.
Increasing dedicated diabetes research projects and swelling government funds for therapeutic research are also expected to elevate the market for type 1 diabetes (treatment) over the next few years. Rising preponderance of juvenile diabetes, coupled with burgeoning cases of early detection, are likely to foster the demand for T1D treatment and therapeutics on a large scale.
Development of several non-insulin therapies, such as adjuvant therapy, is currently in the pipeline. This may provide a strong impetus to the market growth in near future. Furthermore, few of the leading insulin brands, including Eli Lily, Sanofi, and Novo Nordisk, are due for patent expirations soon within a couple of years, which highlights rapid growth possibilities for the type 1 diabetes market globally.
Request For Report Sample: https://www.researchreportinsights.com/report/upsample/120124592/Type-1-Diabetes-Market
Owing to an increasing number of chronic disease cases associated with diabetes, the recent past has seen an exploding usage of various insulin delivery devices. The advent of technology in diabetes treatment, paired up with growing patient awareness, will support the market growth during the forecast period. Diabetes control and awareness programs organized by several governments and private bodies are anticipated to further bolster the market growth.
The entry of biosimilars has been quite promising, resulting in rapid adoption in the therapeutics world. However, emergence of biosimilars can restrict the growth of type 1 diabetes treatment market. Moreover, cost-intensive diagnostics and treatment will remain longstanding challenges to market penetration in developing countries. Inadequate reimbursement policies are also estimated to restrict market growth in near future. Associated side effects can also hamper the rate of adoption.
Global Type 1 Diabetes Market: Trends and Opportunities
Research Report Insights indicated the sustenance of human insulin and insulin analogs at the forefront among all the therapies, owing to the fact that no other therapeutic alternatives assure complete regeneration of the pancreatic beta cells. Moreover, various new T1D therapies are queued for approval post-2016. These trends will drive market in near future. A host of opportunities lies in the juvenile diabetes sector.
Some of the strongest trends in the T1D market, include development of a new class of diabetes drugs, emergence of a range of non-invasive diabetes diagnostics and drug delivery devices. These trends are likely to create multiple growth opportunities in the type 1 diabetes market. Another popular trends is the growing demand for home infusion therapy and artificial pancreas for addressing diabetes.
Global Type 1 Diabetes Market: Regional Analysis
Research Report Insights’s report evaluates the following key geographies:
North America (the U.S, Canada)
Europe (France, Germany, Italy, Spain, and the U.K.)
Eastern Europe
CIS
Asia Pacific (China, India, Japan, Australia, others)
Latin America (Argentina, Brazil, others)
Request For Report TOC: https://www.researchreportinsights.com/report/TOC/120124592/Type-1-Diabetes-Market
North America is currently dominating the global type 1 diabetes market, and will possibly continue its dominance throughout the forecast period. Massive rise in type 1 diabetes cases across North America and highly advanced healthcare infrastructure to address the prevalence of diabetes, will play the key role in boosting the market for type 1 diabetes treatment in this region. Despite sustainably higher costs for diabetes treatment and therapeutics compared to other developed regions, the U.S. is likely to remain the key market for type 1 diabetes over the next few years.
APAC is expected to witness substantial growth during the next few years, by 2021 end. Growing diabetes incidences, increasing geriatric population, and rising life expectancy will collectively fuel the market in this region, especially in Japan, China, and India. Besides the U.S. and Japan, the U.K., Canada, France, Germany, Spain, and Italy will also continue to represent major markets for type 1 diabetes.
Global Type 1 Diabetes Market: Key Players
Some of the key players in the global type 1 diabetes market are Sanofi-Aventis US, LLC, Novo Nordisk A/S, Eli Lilly and Company, B. Braun Melsungen AG, Biodel, Inc., DiaVacs, Inc., Macrogenics, Inc., XOMA Corp., and Astrazeneca Plc.
Report Analysis:https://www.researchreportinsights.com/report/upcomming/120124592/Type-1-Diabetes-Market
0 notes
Text
Global Seasonal Affective Disorder Market in-Depth Analysis, Forecasts, Applications, Shares, Key Players are Biogen, Bristol-Myers Squibb Company, Baxter, Novartis AG, Shire, AstraZeneca, Beurer GmbH by 2017
Data Bridge Market Research added new report “Global Seasonal Affective Disorder Market“ accounted to USD 520.0 million in 2016 growing at a CAGR of 4.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Global Seasonal Affective Disorder Market Definition:
Seasonal affective disorder (SAD) is a type of depression or disorder which is related to changes in seasons. SAD frequently happens due to reducing light exposure to sunlight and occurs during a certain time of the year. Women are mostly affected with SAD who aged between 15 to 55 years.
This Report Contains:
· No of Pages: 350
· No of Figures: 60
· No of Tables: 220
Get Free Sample of Global Seasonal Affective Disorder Market Report Visit @-:
http://databridgemarketresearch.com/request-a-sample/?dbmr=global-seasonal-affective-disorder-market
Global Seasonal Affective Disorder Market Drivers and Restraints:
· Rise in geriatric population
· Increasing awareness among the people
· Favorable reimbursement scenario
· Change in lifestyle
· Growing market for generic drugs
View Detail TOC of Global Seasonal Affective Disorder Market report Visit @
http://databridgemarketresearch.com/toc/?dbmr=global-seasonal-affective-disorder-market
Segmentation of Global Seasonal Affective Disorder Market
By type the global seasonal affective disorder market is segmented into fall and winter sad, spring and summer sad, others.
On the basis of diagnosis the global seasonal affective disorder market is segmented into physical exams, lab tests, psychological evaluation, others.
On the basis of treatment the global seasonal affective disorder market is segmented into phototherapy, medications, psychotherapy, counseling.
Psychotherapy is further sub segmented into art therapy, attachment-based psychotherapy, behavioral therapy, body psychotherapy, cognitive analytical therapy (cat), existential psychotherapy, gestalt therapy.
On the basis of end user the global seasonal affective disorder market is segmented into hospital, clinics, academic institutes, medical research centers.
On the basis of distribution channel the global seasonal affective disorder market is segmented into hospital pharmacies, retail pharmacies and drug stores, online pharmacies.
On the basis of geography, global seasonal affective disorder market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Seasonal Affective Disorder Top Companies:
· Janssen Pharmaceuticals, Inc.,
· Pfizer Inc.,
· Merck & Co., Inc.,
· GlaxoSmithKline plc.,
· Sanofi,
· Eli Lilly and Company,
· Biogen,
· Bristol-Myers Squibb Company,
· Baxter,
· Novartis AG,
· Shire,
· AstraZeneca,
· Beurer GmbH,
· Koninklijke Philips N.V.,
· Lumie, Verilux, Inc.,
· AbbVie Inc.,
· ALLARGAN,
· F. Hoffmann-La Roche Ltd.,
· Henry Schein, Inc.
· Among Others
Browse Detailed of TOC, Inquiry and Analyst call on Global Seasonal Affective Disorder Market Report Visit @: http://databridgemarketresearch.com/reports/global-seasonal-affective-disorder-market/
Related Market Insights:
Global Human Insulin Drugs and Delivery Devices Market – Industry Trends and Forecast to 2024
Global Human Insulin Drugs and Delivery Devices Market, By Product Type, By End-User, By Distribution Channel, By Geography (North America, South America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA)) – Industry Trends and Forecast to 2024
More Insights: http://databridgemarketresearch.com/reports/global-human-insulin-drugs-and-delivery-devices-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]
Investor: [email protected]
Visit Blog http://databridgemarketresearch.com/blog/
Follow us on LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
#Seasonal Affective Disorder#Seasonal Affective Disorder Market#Seasonal Affective Disorder 2017#Seasonal Affective Disorder Trend#Seasonal Affective Disorder Future#Seasonal Affective Disorder top companies
0 notes
Last Seen Blogs
petalheartz
Petalheartz
layoutstan
t.
starr-finn
𝓡𝓮𝓺𝓾𝓮𝓼𝓽𝓼: 𝓞𝓹𝓮𝓷!
boltrek
Senza titolo
letsloveourselfplz
Octopus